A PARADIGM SHIFT IN RESEARCH PUBLISHING
A conceptually novel, WORLD-CLASS PLATFORM FOR AUTHORS WORLDWIDE
Embarking on a pioneering venture, Genomic Press is slated to have its first journals launched in 2024. What is our raison d’être? We bring about a transformation in scientific publishing by fully engaging with and supporting authors. Our fair-cost platform will offer rapid and decisive review of high-quality work. We will then use contemporary tools to actively disseminate your work worldwide. We bring together scientists from multiple disciplines, providing the most exciting, emerging science an unparalleled stage for visibility.
Launching in 2024
We are excited to share the upcoming launch of our three inaugural journals in 2024. These can be accessed through our Journals webpage or by going directly to each journal’s home page by clicking on the journal covers below.
If your work is not aligned with existing dogma, send it to us!
Genomic Press takes pride in maintaining key attributes that shape the essence of all our publications. Discover here these integral elements as they come alive in our forthcoming journals.
At Genomic Press our ultimate goal is to support the advancement of science by providing a platform where cutting-edge work is rapidly assessed, improved thanks to thoughtful and fair reviews, and then rapidly disseminated through the use of the active use of the tools of social media, press releases, and other forms of rapid communication. The development of innovative approaches for handling an ever-increasing volume of submissions first requires the personalized prioritization of manuscripts. We offer our authors a highly personalized approach to the peer review process that we aim at constructively improving our submissions, and not as a barrier to innovation.
The implementation of rigorous standards in peer review aims to ensure quality control, mitigate errors, and advance scientific discoveries. Our journals will optimize the peer review process to ensure optimal content curation findings before worldwide dissemination of your exciting work.
With this in mind, our intensive and personalized focus on the peer review process will differentiate Genomic Press publications and result in fair and rapid peer review of your work.
Navigating the complexities of scientific publishing, Genomic Press emerges as a pioneering force, anchoring its principles in the swift and impartial execution of editorial decisions. This distinguishing feature not only serves as a testament to our commitment and expertise but also sets us on a path to reshape the future of research communication in a way that is timely and just.
The driving force behind scientific and technological progress is research, the very essence of knowledge creation, policy formation, and innovation. However, its true potential is only unleashed when it is efficiently disseminated. Hence, the faster and more equitable this process, the greater the momentum of progress.
Researchers today face mounting pressure to publish their work rapidly. Delays in the editorial decision-making process can impede the pace of innovation and obstruct the sharing of valuable knowledge. Genomic Press recognizes this urgency and guarantees rapid editorial decisions, effectively catalyzing the transition of research from the confines of a lab to the global stage.
In an era marked by global collaboration and cross-disciplinary research, fairness in editorial decisions is of paramount importance. The opportunity to have one’s work assessed on its own merits, free from bias or prejudice, isn’t merely a marker of ethical standards; it is a fundamental right for all researchers. Genomic Press assures such fairness, attracting diverse, high-quality submissions, and creating a repository of wide-ranging scholarly content.
At Genomic Press, we prioritize speed and impartiality in our editorial decision-making process. We pledge to offer swift and unbiased evaluations of your submissions. This ensures your research reaches its audience in a timely manner, free from bias, contributing effectively to the vast body of global knowledge.
Our commitment to fair editorial decisions means each manuscript is evaluated based on its intellectual merit alone, disregarding factors such as authors’ geographic location, institutional affiliation, or area of research. This guarantees an equitable platform for all authors, nurturing a culture of trust, respect, and diversity.
Genome Press isn’t just a participant in the publishing field; we are redefining its very contours. Our dedication to rapid and fair editorial decision-making is creating a new era, where the efficiency and integrity of editorial decisions serve as catalysts for scientific advancement and knowledge sharing. We invite you to be a part of this transformation and experience a publishing journey that is as it should be: fast, fair, and centered around your research.
The editorial process is complex and multifaceted. In cases where reviewers are in agreement, the editor’s task becomes more straightforward, requiring little intervention. However, when there is disparity among the reviewers, the editor’s role becomes critical. The “review number 3” phenomenon has been widely discussed as a prime example of the latter scenario, in which an exceptionally negative, divergent review counters two highly positive ones.
Rather than being constrained by such a scenario, our experienced editors will undertake a personalized approach to each case, taking into consideration all angles. It is possible that the two kind reviewers may have overlooked an important factor, while Reviewer #3 may have identified a fatal flaw. In other cases, the positive reviewers may have seen the potential of a new direction, while Reviewer #3 may object to anything that does not align with their orientation. In this regard, we will ensure that your paper is not bogged down in endless iterations with Reviewer #3.
If the negative criticism has a solid scientific basis, we may reject your work, but we will override the negative review if the negativity is unwarranted and you have provided a professional and scientifically compelling response.
Our online platforms and targeted communication strategies facilitate scientific engagement and collaboration. Through careful analysis of user engagement and feedback, we identify critical areas for improvement and continuously work to enhance user experience.
Our data-driven approach to website design and content creation ensures that our resources remain relevant and valuable to the scientific community.
Moreover, our personalized outreach efforts enable us to connect with leading researchers and institutions, fostering meaningful dialogue and knowledge-sharing. Through these efforts, Genomic Press will highlight your work in advancing scientific discovery and innovation and empower researchers with the tools and resources necessary to achieve their goals.
In the digital age, the influence of social media on information dissemination is undeniable. Recognizing the enormous potential of these platforms, Genomic Press is committed to offering each author broad and dynamic social media engagement for their published work.
Our social media strategy is designed to harness the power of the top five social media platforms to maximize the visibility and impact of your research. These platforms include Facebook, Twitter, LinkedIn, Instagram, and YouTube. Each serves a unique role in reaching diverse demographics, engaging with professional communities, and facilitating dynamic discussions around your work.
Facebook’s vast user base helps us bring your research to a wide-ranging audience, sparking conversations and promoting your work among research communities and beyond. With Twitter’s real-time update feature, we share key findings of your research promptly, engaging with a global community of researchers, academicians, and enthusiasts alike.
LinkedIn allows us to target a more professional demographic, providing exposure to industry leaders, potential collaborators, and organizations that could benefit from your work. Instagram, with its visual-centric approach, helps distill complex research into digestible, impactful posts, making your work more accessible to the broader public. Lastly, YouTube offers us the possibility of utilizing video summaries and author interviews to highlight the key aspects of your research in an engaging and comprehensive manner.
In essence, our broad and dynamic social media engagement strategy ensures your research is not only published but also publicized effectively across diverse platforms, maximizing its reach, impact, and contribution to the scientific community.
At Genomic Press, we understand that publishing your research is the first step in its journey. The true impact of scientific discovery is realized when it reaches the broadest possible audience, resonating within the scientific community and beyond. To this end, we are committed to utilizing press releases to highlight your work, ensuring that all submitted research gains the recognition and exposure it deserves.
Articles that we publish at Genomic Press carry the potential to advance science and improve health, and we are therefore highly committed to showcasing these vital breakthroughs. We forge close relationships with authors and their institutions, collaborating to craft comprehensive press releases for all significant articles we publish. Each press release condenses the essence of your research into a concise, captivating, and accessible narrative, acting as a beacon that attracts diverse audiences. We acknowledge that some institutions prefer to produce their press releases, and we are more than happy to coordinate timing with them. However, regardless of any press releases your institution might create, we will produce our own unless you instruct us not to do so.
To ensure that your work gets extensive exposure worldwide, our Press Releases will be disseminated by EurekAlert!, a nonprofit news-release distribution platform operated by the American Association for the Advancement of Science (AAAS, the publishers of Science) as a resource for journalists and the public. Established in 1996, EurekAlert! hosts news releases produced by universities, journal publishers, medical centers, government agencies, corporations, and other organizations engaged in all disciplines of scientific research, and those releases are widely used by journalists from all countries.
This initiative underpins our commitment to supporting your research journey and actively promoting your accomplishments. We are invested in providing your groundbreaking work with the platform it needs to stimulate discourse, inspire innovation, and contribute to improving our global community.
Genomic Press heralds a transformative model in scientific publishing by embracing an academic-driven approach rather than a profit-driven one. We are inspired by a deep reverence for scientific inquiry and a commitment to empowering researchers, educators, and readers alike.
We believe in the principle of fair pricing. Our endeavor is not to maximize profits but to foster an environment where knowledge can thrive without barriers. By keeping our services affordable, we ensure that high-quality scientific research remains accessible.
Our emphasis on quality is uncompromising. We diligently work to provide unparalleled service that elevates your research, celebrating it as an essential contribution to the global academic discourse.
At Genomic Press, we are not merely publishing research but nurturing an academic community bound by the pursuit of knowledge. We invite you to join us in this exciting journey where academic values are championed, quality is celebrated, and fair pricing is a commitment, not an exception.
At Genomic Press, we believe that Article Processing Charges (APCs) should be synonymous with superior service. We understand that APCs represent a significant investment in your research journey, and we have to ensure this investment yields exceptional returns.
Every APC goes beyond simply facilitating publication; it opens a gateway to comprehensive support, meaningful engagement, and widespread dissemination. Your research is carefully curated, meticulously peer-reviewed, and artfully presented to resonate with a diverse audience.
We emphasize promoting your work, utilizing state-of-the-art tools to ensure your research is noticed, read, and cited. From our robust social media strategies to carefully crafted press releases, we leave no stone unturned in maximizing your research’s exposure.
In essence, the APC at Genomic Press is not just a fee; it is a passport to a suite of services designed to amplify the impact of your work, justify your investment, and enhance your scientific journey.
Genomic Press is poised to initiate a novel strategy in scientific publishing. We are not simply launching another platform but pioneering an affordable, inclusive, dynamic, and globally accessible scientific community. We acknowledge that science is a universal language capable of transcending geographical, cultural, and socio-economic barriers. Guided by this belief, we have designed our platform to be fair-priced and universally accessible, ensuring that research from every corner of the world receives the recognition it deserves.
Moreover, our commitment extends beyond publishing. By leveraging advanced digital strategies and cross-platform synergies, we amplify the reach of your work, inviting global engagement and dialogue.
We aim to break down the barriers that restrict knowledge flow, ensuring that ground-breaking research is not limited to elite circles but benefits humanity. With Genomic Press, you are not just part of a publication platform but an integral contributor to a global academic community that is revolutionizing access to knowledge and redefining scientific reach.
Join us as we create a world where science is not confined but shared, appreciated, and celebrated universally.
CUTTING-EDGE RESEARCH in multiple areas
Significant advancements have been made in multiple areas of medicine; however. the primary focus of Genomic Press will be centered on exploring the intricacies of neuroscience. In this expansive domain, our coverage will encompass research endeavors, from fundamental basic exploration and discovery at the mechanistic level all the way to the translational and clinical spheres, as well as societal implications – including epidemiology and population science.
The concept of health and disease being on a continuum, from genes to society, is at the core of contemporary scientific understanding. Health and disease are not separate entities, but rather part of a broader spectrum that integrates a range of biological, psychological, and social factors. Current research continues to unravel the complex interplay between genetics, environmental factors, and the social determinants of health in shaping individual and population-level health outcomes.
We will accept papers that cover topics in any areas of this vast continuum.
Advancements in medical technologies and genomic science have tremendously enhanced our abilities to identify disease risk and develop targeted interventions that take into account both individual and societal factors. As researchers and healthcare providers work together to bridge the gap between scientific knowledge and real-world application, we can strive towards a more holistic and effective approach to promoting health and preventing disease for all.
Our highest priority is to publish research in any areas of the vast continuum from genes to society that is either conceptually innovative or medically significant and that contributes to the advancement of knowledge in the field. This covers both comprehensive studies as well as single noteworthy findings or observations on cutting-edge topics, and we value work that provides different perspectives.
We are especially intrigued by research that has the potential to challenge and change existing dogma, going beyond traditional hypotheses that have already been explored for decades. Our goal is to promote the development of new theories and breakthrough ideas that will drive novel research directions and become the basis for the therapeutics of the future.
Complete stoRies OR OBSERVATIONS?
At Genomic Press, we’re not just about publishing articles but about sharing complete, comprehensive stories. We understand large-scale projects’ far-reaching implications and appreciate their intricate depth. We recognize that these extensive explorations in psychiatry, clinical neurosciences, and basic neuroscience need room to breathe, and they should be shared in their entirety.
Unlike other platforms, we provide the necessary space to narrate your scientific journey. Our “Articles” category is designed specifically for this purpose. We do not restrict authors with stringent word limits, allowing the detailed exposition of your findings to unfold naturally.
Our Articles allow you to showcase the methodologies employed, discoveries made, and implications these could have on the scientific community and beyond. Essentially, we provide the canvas, and we invite you to paint your full-length research story without abridgment. With Genomic Press, every detail of your comprehensive research narrative finds a home.
In the dynamic landscape of scientific research, it is only sometimes feasible or desirable to wait for an entire project completion before sharing groundbreaking observations with the world. To facilitate the rapid dissemination of significant findings, Genomic Press offers two manuscript types tailored for succinct yet significant contributions: Reports and Research Letters.
Reports are ideal for presenting a set of compelling observations or a concise study. With a maximum length of 3000 words, including an abstract, authors have ample space to detail their research without diluting its essence. Reports may feature 3-4 display items, a combination of figures and tables, and can cite up to 30 references. This format allows authors to deliver impactful, well-contextualized findings in a condensed format.
On the other hand, Research Letters offer an even more streamlined avenue for sharing research. With a word limit of 1500 words and no formal abstract, these letters commence with a synthesizing paragraph to provide context. They may include 1-2 display items and up to 15 references. This succinct format is well-suited for rapidly communicating preliminary observations or concise results while maintaining a rigorous and clear work presentation.
With both formats, Genomic Press enables researchers to promptly share their novel insights, catalyzing the pace of scientific dialogue and discovery.
Regardless of the chosen manuscript type – Articles, Reports, or Research Letters – all submissions should culminate in a crisp, impactful, and novel conclusion. This is your opportunity to solidify the significance of your findings, underline their novelty, and point towards future research directions. It is essential to ensure that your conclusion encapsulates your research findings and conveys their implications within the broader scientific landscape.
Whether your manuscript takes the form of a comprehensive article, a condensed report, or a streamlined research letter, strive to leave your readers with a clear understanding of the value and novelty of your work. At Genomic Press, we believe that a well-crafted conclusion is the pivotal culmination of your narrative, serving as the lighthouse guiding your readers to the full depth and breadth of your research insights.
How to prepare your paper for submission
The foundation of every successful scientific manuscript, be it an Article, Report, or Research Letter, is a clear, relevant idea combined with compelling and exciting findings.
Start with a clear hypothesis or research question that fills a gap in the current understanding of your field. It should inspire intrigue and curiosity, driving your study forward. Your findings should answer this research question and instigate further exploration, sparking new questions and leading to more extensive investigations. Discuss your results within the broader context of your field to emphasize their significance, thereby attracting interest and paving the way for future research.
Deciding on the appropriate manuscript type for your research is essential to ensure your work is presented accurately and comprehensively. Genomic Press offers three distinct formats for your convenience.
For exhaustive research projects where every detail counts, an Article provides an avenue for the complete story. There are no oppressive word limits, allowing you to delve deeply into your study, sharing every twist and turn of your scientific journey.
If your research offers a compelling set of observations yet does not weave a complete story, consider submitting a Report. Reports can be up to 3000 words long, include an abstract, 3-4 display items (figures or tables), and reference up to 30 other works. This format allows authors to share their noteworthy findings swiftly, driving the scientific discourse forward.
A Research Letter may be the ideal choice if you have conducted a brief yet significant piece of research. Research Letters can be maximum of 1500 words and include an introductory paragraph that encapsulates the essence of the work, 1-2 display items, and up to 15 references.
Whichever format you choose, comply with the guidelines regarding word count, display items, and references to ensure your manuscript can be processed smoothly and efficiently.
Whether you are preparing an Article, Report, or Research Letter, your manuscript should be transparent, understandable, and pertinent. Strive for clear and concise writing, avoid overly technical jargon that might exclude a broader audience, and ensure your arguments follow a logical structure. Your research should be set firmly within the context of the current scientific dialogue in your field, and its relevance should be apparent to your readers.
Highlight the novelty and significance of your findings, pointing out their unique contribution to your field. Remember to provide sufficient background information to allow readers to understand where your work fits into the broader context of your discipline.
To ensure relevance, illustrate how your study advances existing knowledge or opens up new research areas. Elucidate your study’s implications, be they theoretical, practical, or both, underscoring your work’s broader relevance to the scientific community and society.
By preparing your manuscript with care, precision, and an eye for engaging storytelling, you will ensure it stands out among the sea of submissions, leaving a lasting impression on both reviewers and readers alike.
Depression: A Case Example of Unseen Struggle, Tangible Impact, and Hope
This poignant image illuminates the silent struggle of depression, which affects over 264 million people worldwide. Depression is not just a significant contributor to global disability but also escalates the risk of suicide, with nearly 800,000 lives lost each year. The economic cost is staggering, exceeding $210 billion annually in the U.S. alone. Overall, the societal toll — lost productivity, strained relationships, diminished quality of life — is immeasurable. Genomic Press aims to catalyze breakthroughs in understanding and treating all psychiatric and neurological disorders, including depression, to alleviate its devastating impact on individuals and society.
Decoding the Brain: A Scientific Journey to a Healthier future
With its intricate network of neurons and trillions of synaptic connections, the human brain presents one of the most significant challenges in modern science. Deciphering its complexities holds the key to understanding our thoughts, emotions, and behaviors and forms the bedrock for advancing the treatment of psychiatric and neurological disorders. As Genomic Press undertakes this challenging endeavor, we are optimistic about the immense potential rewards. With every breakthrough, we inch closer to innovative treatments, improved health outcomes, and a better quality of life for millions. This grand pursuit propels us forward, fueling our dedication to fostering research that illuminates the enigmatic corridors of the human brain.
Painting the Brain's Portrait: A Multidisciplinary Masterpiece
The path to discovery necessitates a collaborative, multidisciplinary approach that amalgamates various fields of expertise. Each approach offers a unique piece of the puzzle, from the identification of biomarkers and the advanced algorithms of computational neuroscience to the rigor of clinical research and trials and the profound insights of genetics. The vivid detail of imaging techniques, the complex dynamics of inflammation and the microbiome, and the invaluable knowledge gained from pathology and neuroanatomy all contribute to our understanding. Innovations in stem cell research offer tantalizing glimpses into potential therapeutic pathways, while other critical approaches, such as neuroethology, neuropharmacology, and neuroepidemiology, further enrich our explorations. This exciting and multidisciplinary effort propels us forward, igniting hope for the breakthroughs that lie ahead.
